Reuters logo
BRIEF-Sucampo Pharmaceuticals and Four Irvington Centre Associates enters into second amendment
September 8, 2017 / 9:04 PM / 12 days ago

BRIEF-Sucampo Pharmaceuticals and Four Irvington Centre Associates enters into second amendment

Sept 8 (Reuters) - Sucampo Pharmaceuticals Inc

* Sucampo Pharmaceuticals - On Sept 5, 2017, Co and Four Irvington Centre Associates, LLC entered into a second amendment to lease agreement- SEC filing

* Sucampo-Amendment expands leased premises and increases annual rent to approximately $1.1 million Source text: [bit.ly/2eT2dif] Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below